PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
暂无分享,去创建一个
R. Greil | A. Egle | J. D. Piñón | C. Holler | U. Denk | S. Hofbauer | C. Heyder | J. Piñón